Promus PREMIER™ H7493952820270Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of Promus PREMIER (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729844785), received between Oct 12, 2017 and Sep 30, 2019 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Activation, Positioning or Separation Problem1
- Break1
- Material Rupture1
- Migration1
Patient problems
- No Consequences Or Impact To Patient3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjurySep 30, 2019Migration; Migration
IT WAS REPORTED THAT STENT EXPLANTATION OCCURRED. THE TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND MODERATELY CALCIFIED MID RIGHT CORONARY ARTERY. A 2.75X20MM PROMUS PREMIER DRUG-ELUTING STENT WAS DEPLOYED TO TREAT THE LESION. HOWEVER, THE STENT STUCK TO THE POST DILATATION BALLOON AND CAME OUT OF THE BODY AFTER DEPLOYMENT. THE PROCEDURE WAS COMPLETED WITH A NEW PROMUS STENT. THERE WERE NO FURTHER PATIENT COMPLICATIONS REPORTED. IT WAS FURTHER REPORTED THAT THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE AND THE PATIENT'S STATUS WAS STABLE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9135453 ↗MalfunctionApr 10, 2019Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 2.75X20MM PROMUS PREMIER DRUG-ELUTING STENT WAS USED IN A PROCEDURE. HOWEVER, IT WAS NOTED THAT THE SHAFT BROKE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AND THE PATIENT WAS NOT HARMED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8500893 ↗InjuryOct 12, 2017Material Rupture; Activation, Positioning or Separation Problem; Material Rupture; Activation, Positioning or Separation Problem
IT WAS REPORTED THAT BALLOON RUPTURE AND STENT INADEQUATE APPOSITION OCCURRED. THE TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND HEAVILY CALCIFIED PROXIMAL LEFT ANTERIOR DESCENDING ARTERY (LAD). ROTABLATION WAS PERFORMED WITH A 1.5MM BURR FOLLOWED BY ANOTHER 1.75MM BURR. A 2.75X20MM PROMUS PREMIER DRUG-ELUTING STENT WAS THEN ADVANCED TO TREAT THE LESION. HOWEVER, DURING FIRST INFLATION AT 9 ATMOSPHERES, THE BALLOON RUPTURED. THE STENT WAS DEPLOYED AND BALLOON WAS PULLED NEGATIVE. THE DEVICE WAS REMOVED FROM THE PATIENT'S BODY. SUBSEQUENTLY, ANOTHER NON-BSC BALLOON CATHETER WAS ADVANCED AND DEPLOYED THE STENT SUFFICIENTLY; AND THE PROCEDURE WAS COMPLETED. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6943836 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page